tiprankstipranks
Arcadia Biosciences Appoints Thomas Schaefer as Class I Director
Company Announcements

Arcadia Biosciences Appoints Thomas Schaefer as Class I Director

Don't Miss our Black Friday Offers:

An update from Arcadia Biosciences (RKDA) is now available.

Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanley Jacot’s resignation. Schaefer, who has been with Arcadia since 2020 and its president and CEO since 2022, brings a robust financial background to the role, including a past as a finance director in the food industry and an equity research analyst. His academic credentials include a BBA and an MBA from prestigious institutions, underscoring his expertise in economics and finance.

See more data about RKDA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskArcadia Biosciences Reports Strong Q3 2024 Growth
TheFlyArcadia Biosciences reports Q3 EPS ($1.18), consensus (81c)
Ryan AdistRKDA Upcoming Earnings Report: What to Expect?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App